PIH14 Economic Assessment of Preeclampsia: Screening, Diagnosis, Treatment Options, and Long Term Outcomes, A Systematic Review  by Zakiyah, N. et al.
A506  VA L U E  I N  H E A LT H  1 7  ( 2 0 1 4 )  A 3 2 3 – A 6 8 6  
care (15.6%), others (12.3%), indigestion (2.9%), energy drinks (2.7%), constipation 
(1.9%), antihistamine (0.4%), skin ointments for allergy (0.4%), and skin ointments 
except for allergy (0.2%), respectively. Only 5 people (1%) reported side effects after 
taking OTC drugs and dietary supplements. The most common reason for buying 
OTC medicines and dietary supplements was to choose products they prefer (33.8%); 
some participants had taken OTC drugs and dietary supplements for improving 
overall health status (19.8%). Also, the use of OTC drugs and dietary supplements 
was associated with chronic disease (p= 0.034), education level (p< 0.001), and house-
hold income (p< 0.001), ConClusions: The results demonstrate the prevalence of 
OTC use in the elders for more than 3 months is unsubstantial and multivitamins 
and dietary supplements are commonly taken by the elderly. In addition, the elders 
with chronic diseases, higher income, and/or lower education level are inclined to 
take OTC medicines.
PIH11
IdentIfyIng PotentIally InaPProPrIate MedIcatIon (PIM) and Major 
rIsk factors for HosPItalIzatIon for elderly PatIents adMIttIng to 
teacHIng HosPItal: study froM IndIan PersPectIve
Shah C.S.
SJM college of pharmacy, chitradurga, India
objeCtives: Inappropriate polypharmacy is a particular concern in older people and 
is associated with negative health outcomes. Objective of this study was to identify 
potentially inappropriate medication (PIM) and major risk factors for hospitalization 
in elderly patients. Methods: It was an observational prospective study in semi 
government teaching hospital situated in south India (Karnataka). This study was 
performed for 3 month and data were collected from elderly patients having age above 
60 year who were admitted to medical ward. Results: Current analysis involving 
data of 150 (64 % male) elderly in patients with mean (SD) age of 67.9 (8.13) years. 
Majority of patients (30 %) were diagnosed with asthma followed by cancer (16 %). 
Mean (SD) hospital stay was 15 (5.23) days for cancer followed by 3 (0.77) days for 
asthma patients. Total 24 prescriptions were found with PIM as per beer’s criteria 
2012. Out of which 50 % of the inappropriate medication found exclusively in asthma 
patients. Insulin was reported to be the single most PIM in 25 % of the prescrip-
tions. ConClusions: Asthma was found to be the single most common disease 
leads to hospitalization among elder patients. Cancer was found to be the single 
common disease which increases hospital stay. Group of patients with asthma were 
receiving highest numbers of inappropriate medication compare to other patients.
IndIvIdual’s HealtH – cost studIes
PIH13
PotentIal effIcency and cost savIngs to tHe englIsH nHs By a 
laParoscoPIc aProacH to total aBdoMInal HysterectoMy
Farrugia M.
East Kent University Hospitals NHS Foundation Trust, Margate, England
objeCtives: Hysterectomy is the most common procedure in gynaecology and 
carries a very high patient satisfaction rating by patients. As a result, a number of 
economic benefits arise, including reduction in average length of stay (LOS), as well 
as readmission and surgical site infection rates using a minimally invasive route. 
The cost savings and efficiency gains accrued to the English NHS are presented in 
the form of a budget impact model. Methods: A budget impact model (BIM) was 
developed in order to compare the costs of two treatment strategies – total abdomi-
nal hysterectomy (TAH) and total laparoscopic hysterectomy (TLH). Micro-costing 
data was obtained from EKHUFT for a subset of TAH and TLH procedures. The latter 
was extrapolated at the National level using OPCS-level Hospital Episode Statistic 
(HES) in order to calculate cost and efficiency savings vis-à-vis average LOS and 
readmissions. This calculation relies on a conservative increase in laparoscopic 
adoption from 22 to 30%. Results: In 2013, 25,548 TAH procedures were carried 
out compared to 5,611 TLH. The LOS was 3.6 days for TAH compared to 1.3 days for 
TLH. The readmission rates are significantly higher for TAH at 1.64/1000 procedures 
compared to 0.18/1000 for TLH. The estimated savings on increasing the TLH rate 
nationally by 8% will free 4000 patient days. On taking into account the lower read-
mission rate, lower LOS and potential income from additional procedures carried 
out from additional bed availability, the micro-costing of the procedure shows an 
overall financial benefit to the NHS. ConClusions: A increase in the laparoscopic 
approach to hysterectomy by 8% will result is significant economic benefits for the 
English health service. This study confirmed the reduced LOS, with a lower readmis-
sion rate following the laparoscopic approach. The budget impact of the calculated 
increase in costs of TLH can be absorbed within tariff.
PIH14
econoMIc assessMent of PreeclaMPsIa: screenIng, dIagnosIs, 
treatMent oPtIons, and long terM outcoMes, a systeMatIc revIew
Zakiyah N.1, van Asselt A.1, Baker P.2, Postma M.J.1
1University of Groningen, Groningen, The Netherlands, 2Gravida: National centre for Growth and 
Development, The University of Auckland, Auckland, New Zealand
objeCtives: To provide a comprehensive overview of the existing evidence on 
the health economics of screening, diagnosis, and treatment options in preec-
lampsia. Methods: A systematic literature search was undertaken using three 
electronic databases (MEDLINE, Embase, Cochrane) to identify all English language 
full papers published between 1994 and 2014 containing economic evaluation or 
budget impact analysis (BIA) studies concerning the screening, diagnosis, treatment 
and prevention of preeclampsia. In addition, the included studies were appraised 
by means of the Consolidated Health Economic Evaluation Reporting Standards 
(CHEERS) statement and the guidelines on reporting format for budget impact 
analysis (ISPOR Principles of Good practice for Budget Impact Analysis). Results: 
From an initial total of 119 citations, six papers fulfilled the eligibility criteria, five 
of which were economic evaluations and one was a BIA. All studies were published 
best of 53%. The safest treatment in terms of caesarean section risk was titrated 
(low dose) oral misoprostol solution with a probability of being the best of 63%. 
Giving equal weight to both outcomes, titrated low dose oral misoprostol solution 
had the best overall outcomes (average rank of 1.5) followed by vaginal misoprostol 
≥ 50μ g (average rank of 1.6). Cost and utility data are now being gathered to inform 
the cost-effectiveness analysis. ConClusions: The NMA and cost-effectiveness 
analysis will be of value to clinicians, pregnant women, guideline developers and 
policy makers within the NHS. We will discuss how the model can be extended to 
include other types of intervention for induction of labour.
PIH7
exaMInatIon of tHe effIcIency of electrIcal stIMulatIon In case of 
stress and urge IncontInence
Oláh A.1, Turnerné Hilmer H.1, Müller Á.1, Knisz J.1, Fullér N.1, Boncz I.2, Pakai A.3,  
Stromájer-Rácz T.1
1University of pécs, pécs, Hungary, 2Faculty of Health Sciences, University of pécs, pécs, Hungary, 
3University of pécs, Zalaegerszeg, Hungary
objeCtives: Electrical stimulation is one kind of conservative treatment in uri-
nary incontinence. Electrical stimulation can trigger the contraction of pelvic floor 
muscles, the functioning of these muscles can be improved, and the strength of 
muscle contraction can be increased as well. The aim of this research is to examine 
the efficiency of electrical stimulation treatment in case of stress and urge inconti-
nence. Methods: In the course of the examination non-random, purposive sam-
pling was applied. Self-made questionnaires were given to the participants before 
and after treatment. Incontinence Impact Questionnaire (IIQ-7) and Urogenital 
Distress Inventory (UDI-6) international valid questionnaires were applied to meas-
ure life quality. The target group was woman clients between the age of 30-65, 
and above 65 years. The examination took place at Kaposi Mór Teaching Hospital, 
Somogy County, from 15 February, 2013 to 15 February, 2014. The analysis of results 
was performed with MS Excel 2007 program. Results: The research was conducted 
with 100 participants. In the course of the examination 45% of the participants 
reported improvement after treatment regarding stress incontinence while in case 
of urge incontinence only 15% experienced positive change. Due to the treatment 
the number of the regular liner users was decreased. The number of users was 
75 (75%) before treatments, which reduced to 44 (44%) after treatment. Electrical 
stimulation proved to be more efficient in case of stress incontinence than in urge 
incontinence. ConClusions: Follow-up of the participants for several months 
would give information about the long-term benefits of electrical stimulation. In 
the future the improvement of the knowledge of patients on incontinence including 
the methods of conservative treatment is important.
PIH8
effects of a MultIdIscIPlInary HoMe-Based MedIcatIon revIew 
PrograM on HosPItal adMIssIons In older adult sIngaPoreans
Cheen H.H.M., Ong K.Y., Lim S.H., Chng S.G.J., Chen L.L., Lim P.S., Ng S.M., Chang W.T.
Singapore General Hospital, Singapore
objeCtives: The study aimed to (i) evaluate the effectiveness of a multidisciplinary 
home-based medication review (HBMR) program in reducing hospital admissions 
and (ii) determine the prevalence of drug-related problems (DRP) in older adult 
Singaporeans. Methods: A retrospective observational study was conducted at 
an academic medical centre in Singapore. Patients referred to the HBMR program 
between March 2011 and December 2012 were included. Home visits were conducted 
by a team comprising a pharmacist and care coordinators. Frequency of hospital 
admissions was determined 6 months before and after HBMR. DRP identified were 
categorised and their outcomes (resolved/unresolved) recorded by the pharmacist. 
Summary statistics were used to report patient characteristics and prevalence of 
DRP. Incidence of hospital admissions was compared using Poisson regression, while 
paired t-test was used to compare associated costs (in Singapore dollars) and length 
of stay (LOS) before and after HBMR. Results: The analysis included 107 patients 
with mean (SD) age of 75.6 (7.6) years. There were 52 (48.6%) males, and 89 (83.2%) 
were Chinese. The implementation of the HBMR program resulted in a 41% reduction 
in risk for hospital admissions (IRR: 0.59; 95% CI: 0.47 – 0.73, p< 0.001). Mean (SD) 
costs of hospital admissions reduced from $16,957.77 ($16,118.35) before HBMR to 
$7,488.76 ($12,773.40) after HBMR (p< 0.001). In a subgroup analysis of 62 patients 
who had hospital admissions before and after HBMR, mean (SD) LOS decreased 
from 26.5 (22.4) days to 17.6 (17.8) days (p= 0.010). The team identified 525 DRP 
from 1,353 medications reviewed. Of these, 34 (6.7%) and 174 (34.1%) DRPs were 
resolved with and without physician involvement respectively. The most common 
DRP identified were failure to receive drug (n= 163, 31.0%) and untreated indication 
(n= 140,26.7%). ConClusions: The multidisciplinary HBMR program was effective 
in reducing hospital admissions in older adult Singaporeans with multiple DRP.
PIH10
over tHe counter MedIcatIon and dIetary suPPleMents use aMong 
older adults
Lee H.1, Choi S.E.1, Lim J.2, Kang D.1, Lim E.A.1, Cheong C.3
1Korea University, Yeongi-gun, South Korea, 2Korea University, Sejong, South Korea, 3Seoul 
National University, Seoul, South Korea
objeCtives: The aim of this study was to examine the prevalence and patterns 
of over-the-counter (OTC) medicine and dietary supplements use among older 
adults in South Korea for more than 3 months period. Methods: The data were 
drawn from the 2009 Korea Health Panel database by selecting 2,910 Koreans aged 
65 years or older. Data on self-reported OTC drugs and dietary supplements use 
longer than 3 months and demographic characteristics were collected from par-
ticipants using a questionnaire and multiple logistic analysis was performed to 
estimate the factors associated with OTC and dietary supplements use. Results: 
424 of 2,910 (14.6%) older adults took at least one OTC medication or dietary sup-
plement. Most frequently used categories of OTC drugs and dietary supplements 
were vitamins and dietary supplements (46.9%) followed by analgesics (16.7%), gum 
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establishing now in Ukraine. Methods: We performed a retrospective analy-
sis of the real data from 450 medical records of patients who were treated 
in a Lviv Regional Perinatal Center in 2013. The results of our previous study of 
treatment cost of endometriosis in Ukraine were used (Zalis’ka O., Piniazhko O. 
et al. 2014). We used the prices from Ukrainian database of Morion company 
(Kiev) on 01.06.2014 (1 EUR = 16,04 UAH). Results: According to the analysis 
70% of women with endometriosis choose treatment hormones with the dura-
tion of six month usually and 30% of patients undergo surgical treatment. 
Annual direct cost of endometriosis per patient varies from € 224 to € 487 depending 
on the chosen scheme of pharmacotherapy, which differences 2 times. Accordingly, 
costs correlated with clinical severity and patient’s financial position and ability to 
pay. Based on the data of State Statistics Service of Ukraine, we estimated that the 
number of women of reproductive age in Ukraine was 14,7 million in 2013. Therefore 
when to extrapolate data the number of women with endometriosis could amount 
approximately 1,47 million and 1,03 million women would take pharmacotherapy 
instead of surgery. The annual cost of treatment hormones of endometriosis could 
amount from € 230,5 million to € 501,6 million. ConClusions: The economic burden 
of endometriosis in Ukraine demonstrates a significant need in the optimization of 
the management of this disease within the introduction of health insurance system 
and health technology assessment of the applicable hormones.
PIH18
Burden and cost of MultIPle cHronIc dIseases In a large coHort of 
elderly In Italy
Rossi E., Cinconze E., De Rosa M.
cINEcA Interuniversity consortium, casalecchio di Reno, Italy
objeCtives: Life expectancy in Italy is constantly increasing (+2,4 years for men and 
+1,7 years for women from 2001 to 2011) with a consequent effect on health needs 
and expenditure. Furthermore, on overall population, 21% has one chronic disease, 
9,3% two and 8% more than three. The aim of this study is to evaluate the burden 
of multiple chronic diseases and associated costs in a large community setting 
of Italian elderly population, starting from Cineca ARNO Observatory. Methods: 
ARNO Observatory is a comprehensive population-based database which integrates 
since 1987 administrative data from Local Health Units to monitor health data 
in the real world. On a population of 10,5 millions of inhabitants we selected a 
cohort of 2.166.000 (21%) subjects over 65 years. Outpatient drug prescriptions, inpa-
tient hospital discharges, diagnostic, lab tests prescriptions were analyzed during 
2012 to evaluate chronic diseases, multiple chronic conditions and illness direct 
costs. Results: From selected cohort, 82,5% has at least one chronic disease and 
this proportion rises up to 89,6% in over 80s. Hypertension is the most common 
disease (67%), followed by dyslipidemia (30%) and diabetes (18%). Over 50% of elderly 
has multiple chronic diseases but the risk of developing concomitant chronic ill-
nesses rises with ages (60% of people aged > = 85 have comorbidities). Integration 
of administrative data led to the evaluation of cost of illness which varies from 
2.528€ for hypertension to 13.613€ for Acute Coronary Syndrome; the average cost of 
patients with 2 or more comorbidities is twice than patients with only one chronic 
disease. In general, more than a half of cost is due to hospitalization (57%), 27% to 
drugs and 16% to diagnostic exams (16%). ConClusions: Analyses of real world 
data represent an effective tool for the evaluation of elderly population diseases 
and can be a valid instrument to support clinical governance.
PIH19
ePIdeMIologIcal and fInancIal Burden of PreterM laBor 
HosPItalIzatIons – an analysIs of gerMan claIMs data
Wetzka S.1, Fleßa S.1, Lange A.2, Zygmunt M.3
1Department of Health care Management, Faculty of Law and Economics, Ernst-Moritz-Arndt-
University Greifswald, Greifswald, Germany, 2Department of Neonatology and pediatric Intensive 
care, Hospital for pediatrics, University of Greifswald, Greifswald, Germany, 3Department of 
Obstetrics and Gynecology, University of Greifswald, Greifswald, Germany
objeCtives: Preterm Labor (PTL) in pregnant women is a common obstetrics inpa-
tient diagnosis. It is important to differentiate between threatened PTL associated 
with potentially avoidable hospitalization and PTL resulting in a preterm birth (PTB) 
with respect to their burden to the health care system. The prevention and diag-
nostic-driven reduction of such hospital admissions for observational reasons are 
supposed to reduce costs. The aim is to analyze the epidemiological and financial 
impact of programs to prevent avoidable hospital admissions due to threatened 
PTL. Methods: A cohort of singletons at the University hospital Greifswald with 
PTL-related hospital admissions prior to birth was analyzed with respect to resource 
use and obstetrics outcomes. This bottom-up analysis was conducted from the 
perspective of the statutory health care system based on accounting information 
claims from the hospital`s database for the period 2007 to 2012. ICD-10 codes were 
used to identify the study population. All costs were inflated to 2012 using the 
German GDP index. Results: Out of 4,408 singleton births, potentially avoidable 
hospital admissions were found in 248 cases (5.6 %). In this subgroup, 17 infants 
were delivered preterm (avg. 34.8 weeks), resulting in a PTB rate of 6.9 % compared 
to a general rate of 8.7 % in Germany. These hospitalizations led to average costs of 
about 1,600 EUR per case (min. 300 EUR; max. 5,600 EUR). ConClusions: Although 
threatened PTL affects one singleton pregnancy in 20, the fraction of costs result-
ing from observational admissions associated with threatened PTL is less than 0.7 
percent compared to the total department costs. This finding conflicts with the 
cost-saving potential of prevention programs (e. g. pH self-assessment) suggested 
in the literature.
PIH20
IncIdence and long-terM cost of oral steroId-related adverse 
events In cHronIc dIseases In Poland
Garbacka M.1, Zapalska A.1, Borowiack E.1, Tronczyñska D.2, Wepsiec K.2, Dziurda D.2, 
Krzyzanowska A.2
1NUEVO HTA cLp, cracow, poland, 2GlaxoSmithKline, Warsaw, poland
between 2001 and 2012. One study was on early screening using maternal markers, 
and concluded that this may be cost-effective from a payer perspective. Three other 
studies focused on treatment and management, and concluded that induction of 
delivery is the most cost-effective option in term preeclampsia. Also, magnesium 
sulphate was found to be a cost-effective treatment, but more so in low income 
countries. One study was a comprehensive HTA report on combination strategies 
of screening and prevention, which found that providing calcium to all pregnant 
women without prior testing was the most cost-effective strategy. The BIA, on intro-
ducing a novel diagnostic test, concluded that the savings associated with this test 
would offset its initial cost. ConClusions: Novel biomarkers in screening for and 
diagnosing preeclampsia show promise as a cost-effective approach, from a payer 
perspective. Moreover, magnesium sulphate seemed to be a cost-effective option 
to manage seizures in preeclamptic women while delivery remains the ultimate 
efficient treatment, especially for women with term preeclampsia.
PIH15
PrIce varIatIon In oBstetrIcal servIces In a rural state
Erten M.Z., Phillips J., Jones C., Kappel S., Meyer M.
University of Vermont - college of Medicine, Burlington, VT, USA
objeCtives: To determine and quantify the level of price variation in inpatient care 
for obstetrical services across hospitals in the State of Vermont, USA. Methods: 
We used data from Vermont Healthcare Claims Uniform Reporting and Evaluation 
System (VHCURES) for the calendar year 2012. We generated single-line summaries 
for all inpatient obstetrical services with an admission date in 2012. We excluded 
records for Medicaid, secondary payments either to Medicare or another commer-
cial insurance, denied claims, non-VT resident claims and adjustments to existing 
claims. This produced a total of 4,019 records for the evaluated services from 13 
Vermont hospitals. We calculated the allowed amount for each Diagnosis Related 
Group (DRG) (total amount a hospital received from a payer, including any prepaid 
amounts related to the service, plus the amount due from a patient through copay-
ment, co-insurance and deductible). The outcome of interest is the average price 
of a specific DRG at each hospital as a percent of group average price in Vermont 
Hospitals. To reflect patient severity we adjusted prices by case-mix. Results were 
generated for hospitals only when there were at least 10 discharges in a specific 
hospital. Results: The average prices for a vaginal delivery with complicating diag-
noses varied between 66% to 156% of the group average, vaginal delivery without 
complicating diagnoses varied between 74% to 182%, neonate with other significant 
problems varied between 60% to 206% and normal newborn varied between 77% to 
180%. ConClusions: There is wide variation in payments for obstetrical services 
across Vermont hospitals. Further analysis is necessary to understand the role of 
various factors that contribute to this variation. During this transition period to a 
single-payer system in the rural state of Vermont, policy makers will need evidence-
based information to ensure undiminished access to care in obstetrical services.
PIH16
MalnutrItIon In InstItutIonalIzed and coMMunIty-dwellIng  
older adults In sPaIn: estIMates of Its costs to tHe natIonal  
HealtH systeM
Rodríguez-Mañas L.1, Abizanda P.2, Barcons N.3, Lizán L.4
1Getafe University Hospital, Madrid, Spain, 2complejo Hospitalario Universitario de Albacete, 
Albacete, Spain, 3Nestlé Health Science, Barcelona, Spain, 4Outcomes 10, castellon, Spain
objeCtives: To estimate the economic impact of malnutrition on annual direct 
cost in Spanish institutionalized or community-dwelling older adults. Methods: 
A systematic review was carried out on the economic burden and use of medi-
cal resources associated with malnutrition in institutionalized or community-
dwelling older adults. National and international databases until December 2013 
were searched. Based on results from the literature review, an Excel-based tool 
was developed to estimate the annual cost difference between malnourished and 
well-nourished institutionalized and community-dwelling older adults in Spain. 
Malnutrition prevalence, annual frequency of general practitioner (GP) visits and 
hospitalizations were the main inputs considered in the model. Unit costs were 
derived from health care cost databases available in Spain (Euros, 2014). One-way 
sensitivity analysis (OWSA) was performed. Results: The results of the systematic 
review showed that malnutrition implies higher medical costs in the study popula-
tion, particularly due to the length of hospital stay, number of hospital admissions 
and GP visits. Economic results showed that the annual cost associated with the 
use of resources of a malnourished patient (€ 5,000.66) was 3.5 times higher than 
that of a well-nourished (€ 1,433.78). OWSA showed that prevalence of malnutrition 
was the variable with the greatest impact on results. Decreasing the prevalence 
of malnutrition according to minimum values identified in the literature (from 
15.6% and 4.4%, to 2% and 3% in institutionalized and community-dwelling patients 
respectively), caused the annual cost per patient with malnutrition to drop from 
€ 5,000.66 to € 2,511.83, while increasing it to the maximum values (62% and 23%, 
respectively), implied a rise from € 5,000.66 to € 24,291.93 in the annual cost per 
patient. ConClusions: Adopting measures to reduce the prevalence of malnu-
trition in institutionalized or community-dwelling older adults would reduce by 
up to 50% the annual cost per patient associated to GP visits and hospitalizations.
PIH17
tHe Prevalence and cost of Illness In woMen wItH endoMetrIosIs  
In ukraIne
Piniazhko O.1, Zalis’ka O.1, Vernikovskyy I.2
1Danylo Halytsky Lviv National Medical University, Lviv, Ukraine, 2Lviv Regional perinatal center, 
Lviv, Ukraine
objeCtives: Endometriosis affects 10% of women of reproductive age and WERF 
EndoCost study has recently shown that it imposes substantial economic burden 
on society through the reduced economic and personal productivity. The aim of 
the study was to estimate the prevalence of endometriosis and the cost of ill-
ness from the payer’s perspective in Ukraine as the model of health insurance is 
